Pediatric Clinical Trials Market Size, Share, Demand, Opportunity, Outlook, Trends, Revenue, Future Growth Opportunities By 2016-2022

Press Release

It means doing clinical trials of a newly found drug or a new research on children to see its effects.The move was started by Edward Jenner, founder of smallpox vaccine, the first documented experiment on children. With the unprivileged sections of the society, the children of orphanages were tested.Towards the end of the nineteenth-century children, social activists protested against the use of children in medical trials.

Market Dynamics
Drug development was solely focused on adults. Because there are legal contracts and ethical issues as well as the consent of the subject, so adult testing was obviously the choice. But children react to drugs in a different way from adults.

Procure this Market Intelligence Report:

Safety and efficacy in children are much more difficult to predict than in adults. Pediatric trials must be inline with the requirement of children. Scheduling a study of medicines effect can lead to frequent visits to the clients thus hampering the kid’s school and the parent’s job.

Market Segmentation
BasedonStudy Design
Based on Therapy Area

Phase 0
Phase 1
Phase 2
Phase 3


Regional/Geographic Analysis
The US holds the top position in terms of market share followed by Europe and Asia Pacific. The US accounted for 86% of the clinical trials out of 346 trials worldwide. However, the trend is changing. Now most of the clinical trials are conducted in China followed by Russia and India.

Key Players
Bombay Bioresearch Centre
Asian Clinical Trials
Cardinal Clinical Research
Report ContentsRegional AnalysisReport Highlights

Market Segments
Pediatric Clinical Trials Market Drivers, Restraints and Opportunities
Pediatric Clinical Trials Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market – Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players

North America
US and Canada

Latin America
Mexico, Brazil, Argentina and Rest of Latin America

Western Europe
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe

Eastern Europe
Rest of Eastern Europe

Asia Pacific
Australia and New Zealand
Rest of Asia Pacific

Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
South Africa
North Africa
Rest of Middle East and Africa

View Source:

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
Consumer and Pricing Analysis
Market dynamics of the industry
Market Segmentation
Estimated Market Sizing in terms of volume and value
Recent trends in Pediatric Clinical Trials Market and impact
Research Status and Technology Overview
Extensive Industry Structure Coverage


Related Articles